Clinical Trial for the Validation of AR Based Neuronavigation System

Not Applicable

Not yet recruiting

• Conditions: Brain Neoplasms; Navigation, Spatial; Cerebral Aneurysm; Cerebral Arteriovenous Malformation
• Interventions: Diagnostic Test: AR-based navigation

• Registration Number: NCT05776706
• Lead Sponsor: Seoul National University Hospital

Brief Summary

The goal of this clinical trial is to test augmented reality (AR) based neuronavigation system in surgeries for patients of brain neoplasm or cerebral vascular disease. The main questions it aims to answer are:

• AR based neuronavigation system can achieve accuracy that is not inferior to conventional intraoperative navigation system.

Participants will participate the study after informed consent. When participants undergo surgery for their brain tumor, we will set up 2 types of neuronavigation, conventional navigation system and developed AR based neuronavigation system. Surgeon will plan and conduct surgery based on only conventional navigation system, but 3D errors at several selected points between two types of navigation will be measured and analyzed.

Detailed Description

Being developed AR navigation were reported in our following papers:

1. Dho YS, et al., Development of an inside-out augmented reality technique for neurosurgical navigation. Neurosurgical Focus. 2021 Aug 1;51(2):E21. (doi.org/10.3171/2021.5.FOCUS21184)

2. Moon HC, et al., Navigation of frameless fixation for gamma knife radiosurgery using fixed augmented reality. Scientific Reports. 2022 Mar 16;12(1):1-0. (doi.org/10.3171/2021.5.FOCUS21184)

This study aims to evaluate the accuracy of anatomical localization of a newly developed augmented reality-based neurosurgery navigation. After 3-dimensional (3D) modeling of the brain of a patient with brain tumor or cerebral vascular disease through 3D image segmentation extraction and modeling, the Augmented Reality (AR)-based navigation developed by this research team can be used with a commercially available visualization device, such as iPad, iPhone, and Hololens2, to evaluate the accuracy.

The AR-based navigation obtained approval from the Ministry of Food and Drug Safety of Republic of Korea (class 2 medical device) in February 2022. Through this clinical tria that compare accuracy with existing conventional intraoperative neuronavigation system, we will evaluate whether it shows equivalent performance to replace the existing navigation.

Study Timeline

• Study First Submitted: 2022-12-05
• Study First Submitted QC: 2023-03-08
• Study First Posted: 2023-03-20
• Status Verified: 2024-11
• Last Update Submitted: 2024-11-30
• Last Update Posted: 2024-12-03
• Study Start: 2025-05-01
• Primary Completion: 2026-12-31
• Study Completion: 2027-12-31

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

• Adult patients aged 18 years or older who underwent MRI or CT scan due to brain tumor or cerebrovascular disease
• Adult patients aged 18 years or older who need surgical treatment using navigation for brain tumor or cerebrovascular disease

Exclusion Criteria

• Cases where application of navigation is not necessary according to the judgment of the researcher or surgeon
• When the patient or guardian does not agree
• Patients with anatomical deformation due to previous surgery or requiring emergency surgery

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Single arm	AR-based navigation	We will set up 2 navigation systems, newly developed AR-based navigation and conventional navigation system, to surgeries of all participants. Surgeons will perform all surgical planning and operations with reference to the conventional navigation system. In this process, the errors of the existing navigation and the newly developed navigation will be measured and compared in 3D at several points, and the points are as follows: 1. Fiducial markers 2. Nasion 3. Tumor's margin (anterior, posterior, superior, inferior)

Primary Outcome Measures

Name	Time	Method
The degree of 3-dimensional error at each measurement points (mm) after durotomy	6 hours	Tumor's margin, ICA bifurcation, et al.
The degree of 3-dimensional error at each measurement points (mm)	6 hours	Fiducial markers, nasion

Secondary Outcome Measures

Name	Time	Method
Time required to set up and use each navigation	6 hours	Time required to match conventional navigation and AR navigation, respectively.
Non-inferiority of AR-based navigation compared to conventional navigation	12 months	Statistical comparison of the average value between the error with the actual position of conventional navigation and the error with the actual position of AR navigation.
Economic analysis for each navigation	12 months	Economic benefits that can be expected if AR-based navigation can replace conventional navigation will be assessed. Cost for surgery, cost of whole admission period, and hospital day will be evaluated.

Trial Locations

Locations (1)

Seoul National University Hospital; 🇰🇷 Seoul, Korea, Republic of